- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Sector: Pharmaceuticals & Biotechnology
|Small Cap
Nectar Lifesciences Share Price
Nectar Lifesciences Ltd.
₹11.75
1.06(9.92%)
10th Apr 2026 | 3:15 PM
NSE : NECLIFE
Open Free Demat Account
Nectar Lifesciences Performance
Price Movement
₹11.75
₹10.82
₹11.75
↘ Today's Low↗ Today's High
1 Year Performance
₹11.75
₹9.30
₹28.25
↘ 52 Week Low↗ 52 Week High
Markets Today
High₹11.75
Low₹10.82
Open at₹10.85
Prev Close₹10.69
Volumes6.33 L
Avg Price₹11.63
Lower Circuit₹9.63
Upper Circuit₹11.75
Historical Performance
3M High₹18.99
3M Low₹9.30
1 Yr High₹28.25
1 Yr Low₹9.30
3 Yr High₹56.50
3 Yr Low₹9.30
5 Yr High₹56.50
5 Yr Low₹9.30
Nectar Lifesciences Fundamentals
Market Cap
Below industry Median
239.70 Cr.
PE Ratio (TTM)
Negative PE TTM
-0.70
Dividend Yield
0
Net Profit TTM
2189% decr over last year
-355.06
Net Profit Growth
2189% decr over last year
-355.06
PEG Ratio
Below industry Median
0
ROE
2683% decr over last year
-11.88
Operating Revenue TTM
716.36
Operating Revenue Growth
57% decr over last year
Book Value
Low in industry
0.30
MFI
MFI is mid-range
45
RSI
RSI is mid-range
46.20
EPS (TTM)
-5.07
Debt to Equity
0.61
Face Value
1
Operating Profit Margin Qtr.
-1.76
Operating Profit Qtr.
-1.92
Net Profit Qtr.
14.27
Operating Revenue Qtr.
0
PB Ratio
0.30
Nectar Lifesciences Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0 | 5 | 280.67 | 430.69 | 454.98 |
| Operating Expense | 1.92 | 6.04 | 342.56 | 585 | 410.27 |
| Operating Profit | -1.92 | -1.04 | -61.89 | -154.30 | 44.71 |
| Depreciation | 0.06 | 0.20 | 16.52 | 15.77 | 15.61 |
| Interest | 30.22 | 0 | 18.70 | 17.67 | 17.12 |
| Tax | -11.02 | -0.18 | -33.52 | -57.58 | 4.71 |
| Net Profit | 14.27 | -176.01 | -63.23 | -130.09 | 7.84 |
Nectar Lifesciences Technicals
Nectar Lifesciences Ltd. EMA & SMA
₹11.75
0.96 (8.90%)
↗ Bullish Moving Average
6
↘ Bearish Moving Average
10
Day EMA5 ₹10.2
Day EMA10 ₹10.3
Day EMA12 ₹10.3
Day EMA20 ₹10.7
Day EMA26 ₹11
Day EMA50 ₹12.2
Day EMA100 ₹13.9
Day EMA200 ₹16.6
Nectar Lifesciences Support and Resistance
Resistance
First Resistance₹11.10
Second Resistance₹11.42
Third Resistance₹11.86
Support
First Support₹10.34
Second Support₹9.90
Third Support₹9.58
Technical Indicators
Day RSI46.20
Day MFI45.00
Day ADX46.32
Day Commodity Channel Index-5.60
William-29.72
Day MACD-0.66
Day MACD Signal Line-0.76
Day ATR0.53
Day ROC125-25.02
Day ROC21-8.48
Nectar Lifesciences Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 44.5 | 44.5 | 44.5 | 44.9 | 44.9 | 51.8 |
| FII | 0.7 | 1.6 | 0.8 | 0.6 | 0.5 | 0.6 |
| DII | 0.1 | 0.2 | 0.2 | 0.1 | 5.9 | 4 |
| Public | 54.7 | 53.6 | 54.4 | 54.4 | 48.7 | 43.5 |
Nectar Lifesciences Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 6.92 L | 10.13 L | 68.37% |
| Week | 4.77 L | 6.7 L | 71.15% |
| 1 Month | 4.52 L | 6.08 L | 74.29% |
| 6 Month | 9.87 L | 16.16 L | 61.09% |
Nectar Lifesciences SWOT Analysis
Strengths7
Weakness9
Opportunity2
Threats0
Price crossing above SMA20 today, and greater than SMA5
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Turnaround companies- loss to profit QoQ
Companies with Zero Promoter Pledge
Companies with decreasing Promoter pledge
Stock with Low PE (PE < = 10)
Nectar Lifesciences Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 11 Sep, 2020 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2019 | 0.05 | FINAL | Equity Share | |
| 19 Sep, 2018 | 0.05 | FINAL | Equity Share | |
| 20 Sep, 2017 | 0.05 | FINAL | Equity Share | |
| 22 Sep, 2016 | 0.1 | FINAL | Equity Share | |
| 22 Sep, 2015 | 0.1 | FINAL | Equity Share | |
| 21 Aug, 2014 | 0.1 | FINAL | Equity Share | |
| 19 Sep, 2013 | 0.1 | FINAL | Equity Share | |
| 20 Sep, 2012 | 0.1 | FINAL | Equity Share | |
| 21 Sep, 2011 | 0.1 | FINAL | Equity Share |
Nectar Lifesciences Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹424.60 | ₹7.36 | ₹106.55 | ₹111.41 | ₹130.95 | ₹19.50 |
| % Change | 0.45% | 4.99% | 0.52% | 5.07% | 7.68% | -3.94% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | - | ₹282.74 | - | - |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | - | ₹15.30 | - | - |
| PE TTM | - | -1.70 | 14.00 | 26.90 | - | 7.00 |
| 1 Year Return | 7.83 | 601 | -17.19 | -15.85 | 33.64 | -52.79 |
| ROCE | 28.91 | -5.63 | - | - | - | - |
Similar Stocks
INFLUX
Influx Healthtech Ltd.
₹ 232.30
+0.24%
MEDIORG
Medicamen Organics Ltd.
₹ 27.65
-9.79%
AMRUTANJAN
Amrutanjan Health Care Ltd.
₹ 535.45
+0.85%
SENORES
Senores Pharmaceuticals Ltd.
₹ 821.95
+2.06%
INNOVACAP
Innova Captab Ltd.
₹ 686.60
+0.85%
VALIANTLAB
Valiant Laboratories Ltd.
₹ 59.99
+3.95%
SIGACHI
Sigachi Industries Ltd.
₹ 22.08
+6.00%
WINDLAS
Windlas Biotech Ltd.
₹ 803.00
+0.48%
VINEETLAB
Vineet Laboratories Ltd.
₹ 32.44
-1.96%
SOLARA
Solara Active Pharma Sciences Ltd.
₹ 486.35
+1.04%
ZIMLAB
Zim Laboratories Ltd.
₹ 73.41
+2.69%
MEDICO
Medico Remedies Ltd.
₹ 38.40
+0.81%
DCAL
Dishman Carbogen Amcis Ltd.
₹ 159.00
+0.35%
LASA
Lasa Supergenerics Ltd.
₹ 7.66
+1.32%
ADVENZYMES
Advanced Enzyme Technologies Ltd.
₹ 298.00
+2.11%
BAJAJHCARE
Bajaj Healthcare Ltd.
₹ 335.10
+3.41%
ORTINGLOBE
Ortin Global Ltd.
₹ 15.02
-2.47%
BROOKS
Brooks Laboratories Ltd.
₹ 72.00
+0.60%
RPGLIFE
RPG Life Sciences Ltd.
₹ 1880.00
-0.38%
BAFNAPH
Bafna Pharmaceuticals Ltd.
₹ 139.00
+2.11%
ALPA
Alpa Laboratories Ltd.
₹ 68.80
-0.81%
SPARC
Sun Pharma Advanced Research Company Ltd.
₹ 147.99
+1.25%
SMSPHARMA
SMS Pharmaceuticals Ltd.
₹ 417.50
+0.60%
FAQ's on NECLIFE
What is the current share price of Nectar Lifesciences Ltd.?
As of 6 June 2025 at 10:01 AM, the share price for Nectar Lifesciences Ltd. is ₹ 11.75 on the NSE and ₹ 11.82 on the BSE. (Note: Prices are dynamic and update frequently during market hours).
What is the Market Capitalization of Nectar Lifesciences Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Nectar Lifesciences Ltd. is approximately ₹ 239.7 Cr.
What are the PE and PB ratios for Nectar Lifesciences Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Nectar Lifesciences Ltd. is -0.7, and the Price-to-Book (PB) ratio is 0.3.
What is the 52-Week High and Low for Nectar Lifesciences Ltd.?
Over the past 52 weeks, the highest price reached by Nectar Lifesciences Ltd. shares was ₹ 28.25, and the lowest price was ₹ 9.3.
Who are the major shareholders of Nectar Lifesciences Ltd.?
Significant shareholdings in Nectar Lifesciences Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Public
- Other Institutions
- FII
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Nectar Lifesciences Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Nectar Lifesciences Ltd. is often compared with other major players such as
Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.
What is the latest dividend information for Nectar Lifesciences Ltd.?
Nectar Lifesciences Ltd. last declared a FINAL dividend of ₹ 0.05 per share for the financial period ending 2020. The record date was set as 2020-09-11, and the payment was/is scheduled around 2020-09-11. For the most current dividend announcements, refer to official company filings.
What is the shareholding pattern for Nectar Lifesciences Ltd.?
As per the filings for the quarter ending Mar 2026, the approximate shareholding pattern for Nectar Lifesciences Ltd. is:
- Promoters: 51.8%
- Domestic Institutional Investors (DII): 4%
- Foreign Institutional Investors (FII): 0.6%
- Others (including Public): 0.1%
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy